Literature DB >> 1334372

Molecular and genetic analysis of a compound heterozygote for dysprothrombinemia of prothrombin Tokushima and hypoprothrombinemia.

H Iwahana1, K Yoshimoto, T Shigekiyo, A Shirakami, S Saito, M Itakura.   

Abstract

The molecular and genetic basis of a compound heterozygote for dys- and hypoprothrombinemia was analyzed. Abnormal nucleotide sequences of the human prothrombin gene were screened by PCR-single-strand conformation polymorphism (PCR-SSCP) with endonuclease digestion and mutated primer-mediated PCR-RFLP. A single nucleotide substitution responsible for dysprothrombinemia of prothrombin Tokushima was detected, as were three polymorphisms. The mutation for hypoprothrombinemia was detected by PCR-single-strand conformation polymorphism (PCR-SSCP) with endonuclease digestion in exon 6, near MboII-RFLP and NcoI-RFLP. Sequencing of PCR-amplified genomic DNA revealed a single base insertion of thymine (T) at position 4177. The resulting frameshift mutation caused both an altered amino acid sequence from codon 114 and a premature termination codon (i.e., TGA) at codon 174 in exon 7. Because exon 7 encodes the kringle 2 domain preceding the thrombin sequence, this frameshift leads to the null prothrombin phenotype. The inheritance of the hypoprothrombinemia gene from the father to the proband was proved by PCR-SSCP with endonuclease digestion and mutated primer-mediated PCR-RFLP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334372      PMCID: PMC1682933     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  The spectrum of beta-thalassemia mutations in Taiwan: identification of a novel frameshift mutation.

Authors:  L I Lin; K S Lin; K H Lin; H C Chang
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

2.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.

Authors:  M Orita; Y Suzuki; T Sekiya; K Hayashi
Journal:  Genomics       Date:  1989-11       Impact factor: 5.736

3.  Observations on the levels of Hb A2 in patients with different beta-thalassemia mutations and a delta chain variant.

Authors:  J F Codrington; H W Li; F Kutlar; L H Gu; M Ramachandran; T H Huisman
Journal:  Blood       Date:  1990-09-15       Impact factor: 22.113

4.  Approach to identification of a point mutation in apo B100 gene by means of a PCR-mediated site-directed mutagenesis.

Authors:  E I Schwartz; S P Shevtsov; A P Kuchinski; O V Plutalov
Journal:  Nucleic Acids Res       Date:  1991-07-11       Impact factor: 16.971

5.  Characterization of polymerase chain reaction amplification of specific alleles.

Authors:  G Sarkar; J Cassady; C D Bottema; S S Sommer
Journal:  Anal Biochem       Date:  1990-04       Impact factor: 3.365

6.  Nucleotide sequence of the gene for human prothrombin.

Authors:  S J Degen; E W Davie
Journal:  Biochemistry       Date:  1987-09-22       Impact factor: 3.162

7.  Congenital dysprothrombinemia.

Authors:  A Shirakami; S Kawauchi
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1984-12

8.  A frame-shift mutation in the cystic fibrosis gene.

Authors:  M B White; J Amos; J M Hsu; B Gerrard; P Finn; M Dean
Journal:  Nature       Date:  1990-04-12       Impact factor: 49.962

9.  Detection of a single base substitution of the gene for prothrombin Tokushima. The application of PCR-SSCP for the genetic and molecular analysis of dysprothrombinemia.

Authors:  H Iwahana; K Yoshimoto; T Shigekiyo; A Shirakami; S Saito; M Itakura
Journal:  Int J Hematol       Date:  1992-02       Impact factor: 2.490

10.  Prothrombin Molise: a "new" congenital dysprothrombinemia, double heterozygosis with an abnormal prothrombin and "true" prothrombin deficiency.

Authors:  A Girolami; S Coccheri; G Palareti; M Poggi; A Burul; G Cappellato
Journal:  Blood       Date:  1978-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.